Selected research
Industry Research
Polymyxin B Sulfate Industry Research Report 2026
Market perspective
The global Polymyxin B Sulfate market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Polymyxin B Sulfate is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Polymyxin B Sulfate is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Polymyxin B Sulfate is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Polymyxin B Sulfate include AKORN, XELLIA PHARMS APS, SANDOZ INC, FRESENIUS KABI USA, Concord Biotech, BAUSCH AND LOMB, AuroMedics and Allergan, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Polymyxin B Sulfate market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Polymyxin B Sulfate Market by Company
AKORN
XELLIA PHARMS APS
SANDOZ INC
FRESENIUS KABI USA
Concord Biotech
BAUSCH AND LOMB
AuroMedics
Allergan
Polymyxin B Sulfate Segment by Type
Tablets
Injections
Polymyxin B Sulfate Segment by Application
Hospitals
Private Clinics
Others
Polymyxin B Sulfate Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Polymyxin B Sulfate market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Polymyxin B Sulfate and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Polymyxin B Sulfate.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Polymyxin B Sulfate manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Polymyxin B Sulfate by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Polymyxin B Sulfate in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Tablets
- Injections
Applications
- Hospitals
- Private Clinics
- Others
Companies covered
- AKORN
- XELLIA PHARMS APS
- SANDOZ INC
- FRESENIUS KABI USA
- Concord Biotech
- BAUSCH AND LOMB
- AuroMedics
- Allergan
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Polymyxin B Sulfate Market Size (2021-2032)
- 2.2.2 Global Polymyxin B Sulfate Sales (2021-2032)
- 2.2.3 Global Polymyxin B Sulfate Market Average Price (2021-2032)
- 2.3 Polymyxin B Sulfate by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Tablets
- 2.3.3 Injections
- 2.4 Polymyxin B Sulfate by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospitals
- 2.4.3 Private Clinics
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Polymyxin B Sulfate Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Polymyxin B Sulfate Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Polymyxin B Sulfate Revenue of Manufacturers (2021-2026)
- 3.4 Global Polymyxin B Sulfate Average Price by Manufacturers (2021-2026)
- 3.5 Global Polymyxin B Sulfate Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Polymyxin B Sulfate, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Polymyxin B Sulfate, Product Type & Application
- 3.8 Global Manufacturers of Polymyxin B Sulfate, Established Date
- 3.9 Global Polymyxin B Sulfate Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 AKORN
- 4.1.1 AKORN Company Information
- 4.1.2 AKORN Business Overview
- 4.1.3 AKORN Polymyxin B Sulfate Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 AKORN Polymyxin B Sulfate Product Portfolio
- 4.1.5 AKORN Recent Developments
- 4.2 XELLIA PHARMS APS
- 4.2.1 XELLIA PHARMS APS Company Information
- 4.2.2 XELLIA PHARMS APS Business Overview
- 4.2.3 XELLIA PHARMS APS Polymyxin B Sulfate Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 XELLIA PHARMS APS Polymyxin B Sulfate Product Portfolio
- 4.2.5 XELLIA PHARMS APS Recent Developments
- 4.3 SANDOZ INC
- 4.3.1 SANDOZ INC Company Information
- 4.3.2 SANDOZ INC Business Overview
- 4.3.3 SANDOZ INC Polymyxin B Sulfate Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 SANDOZ INC Polymyxin B Sulfate Product Portfolio
- 4.3.5 SANDOZ INC Recent Developments
- 4.4 FRESENIUS KABI USA
- 4.4.1 FRESENIUS KABI USA Company Information
- 4.4.2 FRESENIUS KABI USA Business Overview
- 4.4.3 FRESENIUS KABI USA Polymyxin B Sulfate Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 FRESENIUS KABI USA Polymyxin B Sulfate Product Portfolio
- 4.4.5 FRESENIUS KABI USA Recent Developments
- 4.5 Concord Biotech
- 4.5.1 Concord Biotech Company Information
- 4.5.2 Concord Biotech Business Overview
- 4.5.3 Concord Biotech Polymyxin B Sulfate Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Concord Biotech Polymyxin B Sulfate Product Portfolio
- 4.5.5 Concord Biotech Recent Developments
- 4.6 BAUSCH AND LOMB
- 4.6.1 BAUSCH AND LOMB Company Information
- 4.6.2 BAUSCH AND LOMB Business Overview
- 4.6.3 BAUSCH AND LOMB Polymyxin B Sulfate Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 BAUSCH AND LOMB Polymyxin B Sulfate Product Portfolio
- 4.6.5 BAUSCH AND LOMB Recent Developments
- 4.7 AuroMedics
- 4.7.1 AuroMedics Company Information
- 4.7.2 AuroMedics Business Overview
- 4.7.3 AuroMedics Polymyxin B Sulfate Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 AuroMedics Polymyxin B Sulfate Product Portfolio
- 4.7.5 AuroMedics Recent Developments
- 4.8 Allergan
- 4.8.1 Allergan Company Information
- 4.8.2 Allergan Business Overview
- 4.8.3 Allergan Polymyxin B Sulfate Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Allergan Polymyxin B Sulfate Product Portfolio
- 4.8.5 Allergan Recent Developments
5 Global Polymyxin B Sulfate Market Scenario by Region
- 5.1 Global Polymyxin B Sulfate Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Polymyxin B Sulfate Sales by Region: 2021-2032
- 5.2.1 Global Polymyxin B Sulfate Sales by Region: 2021-2026
- 5.2.2 Global Polymyxin B Sulfate Sales by Region: 2027-2032
- 5.3 Global Polymyxin B Sulfate Revenue by Region: 2021-2032
- 5.3.1 Global Polymyxin B Sulfate Revenue by Region: 2021-2026
- 5.3.2 Global Polymyxin B Sulfate Revenue by Region: 2027-2032
- 5.4 North America Polymyxin B Sulfate Market Facts & Figures by Country
- 5.4.1 North America Polymyxin B Sulfate Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Polymyxin B Sulfate Sales by Country (2021-2032)
- 5.4.3 North America Polymyxin B Sulfate Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Polymyxin B Sulfate Market Facts & Figures by Country
- 5.5.1 Europe Polymyxin B Sulfate Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Polymyxin B Sulfate Sales by Country (2021-2032)
- 5.5.3 Europe Polymyxin B Sulfate Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Polymyxin B Sulfate Market Facts & Figures by Country
- 5.6.1 Asia Pacific Polymyxin B Sulfate Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Polymyxin B Sulfate Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Polymyxin B Sulfate Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Polymyxin B Sulfate Market Facts & Figures by Country
- 5.7.1 South America Polymyxin B Sulfate Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Polymyxin B Sulfate Sales by Country (2021-2032)
- 5.7.3 South America Polymyxin B Sulfate Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Polymyxin B Sulfate Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Polymyxin B Sulfate Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Polymyxin B Sulfate Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Polymyxin B Sulfate Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Polymyxin B Sulfate Sales by Type (2021-2032)
- 6.1.1 Global Polymyxin B Sulfate Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Polymyxin B Sulfate Sales Market Share by Type (2021-2032)
- 6.2 Global Polymyxin B Sulfate Revenue by Type (2021-2032)
- 6.2.1 Global Polymyxin B Sulfate Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Polymyxin B Sulfate Revenue Market Share by Type (2021-2032)
- 6.3 Global Polymyxin B Sulfate Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Polymyxin B Sulfate Sales by Application (2021-2032)
- 7.1.1 Global Polymyxin B Sulfate Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Polymyxin B Sulfate Sales Market Share by Application (2021-2032)
- 7.2 Global Polymyxin B Sulfate Revenue by Application (2021-2032)
- 7.2.1 Global Polymyxin B Sulfate Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Polymyxin B Sulfate Revenue Market Share by Application (2021-2032)
- 7.3 Global Polymyxin B Sulfate Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Polymyxin B Sulfate Value Chain Analysis
- 8.1.1 Polymyxin B Sulfate Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Polymyxin B Sulfate Production Mode & Process
- 8.2 Polymyxin B Sulfate Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Polymyxin B Sulfate Distributors
- 8.2.3 Polymyxin B Sulfate Customers
9 Global Polymyxin B Sulfate Analyzing Market Dynamics
- 9.1 Polymyxin B Sulfate Industry Trends
- 9.2 Polymyxin B Sulfate Industry Drivers
- 9.3 Polymyxin B Sulfate Industry Opportunities and Challenges
- 9.4 Polymyxin B Sulfate Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst